145 related articles for article (PubMed ID: 15953425)
41. [Iatrogenic Retinal Artery Occlusions Following Retrobulbar Anaesthesia].
El-Jade M
Klin Monbl Augenheilkd; 2024 Mar; ():. PubMed ID: 38531371
[No Abstract] [Full Text] [Related]
42. [Correction: Intravitreal injections: increasing sustainability by reducing clinical waste].
Birtel J; Hammer M; Feltgen N; Pauleikhoff L; Ong AY; Geerling G; Spitzer MS; Charbel Issa P
Klin Monbl Augenheilkd; 2024 Apr; ():. PubMed ID: 38626881
[No Abstract] [Full Text] [Related]
43. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects.
Li S; Chen L; Fu Y
J Nanobiotechnology; 2023 Jul; 21(1):232. PubMed ID: 37480102
[TBL] [Abstract][Full Text] [Related]
44. SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.
Scott IU; Oden NL; VanVeldhuisen PC; Ip MS; Blodi BA;
Ophthalmology; 2023 Oct; 130(10):1066-1072. PubMed ID: 37220815
[TBL] [Abstract][Full Text] [Related]
45. Glaucoma and Systemic Disease.
Hsu E; Desai M
Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109547
[TBL] [Abstract][Full Text] [Related]
46. In Situ Formation of Injectable Gelatin Methacryloyl (GelMA) Hydrogels for Effective Intraocular Delivery of Triamcinolone Acetonide.
Shen C; Zhao X; Ren Z; Yang B; Wang X; Hu A; Hu J
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902389
[TBL] [Abstract][Full Text] [Related]
47. Ocular Drug Delivery: a Comprehensive Review.
Ahmed S; Amin MM; Sayed S
AAPS PharmSciTech; 2023 Feb; 24(2):66. PubMed ID: 36788150
[TBL] [Abstract][Full Text] [Related]
48. Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab.
Asano T; Kunikata H; Yasuda M; Nishiguchi KM; Abe T; Nakazawa T
Int Ophthalmol; 2021 Jan; 41(1):151-162. PubMed ID: 32894391
[TBL] [Abstract][Full Text] [Related]
49. New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion.
Li J; Paulus YM; Shuai Y; Fang W; Liu Q; Yuan S
J Ophthalmol; 2017; 2017():4936924. PubMed ID: 28386476
[TBL] [Abstract][Full Text] [Related]
50. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
Moon J; Kim M; Sagong M
Eye (Lond); 2016 Aug; 30(8):1084-90. PubMed ID: 27229707
[TBL] [Abstract][Full Text] [Related]
51. Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion.
Zhang S; An N; Ha W; Zhang S; Hu X; Ma A; Zhao B
J Int Med Res; 2016 Jun; 44(3):685-97. PubMed ID: 26936966
[TBL] [Abstract][Full Text] [Related]
52. The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.
Nentwich MM; Ulbig MW
Dtsch Arztebl Int; 2012 Sep; 109(37):584-90. PubMed ID: 23093988
[TBL] [Abstract][Full Text] [Related]
53. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Scott IU; Ip MS; VanVeldhuisen PC; Oden NL; Blodi BA; Fisher M; Chan CK; Gonzalez VH; Singerman LJ; Tolentino M;
Arch Ophthalmol; 2009 Sep; 127(9):1115-28. PubMed ID: 19752420
[TBL] [Abstract][Full Text] [Related]
54. Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).
Fish GE
Trans Am Ophthalmol Soc; 2008; 106():276-300. PubMed ID: 19277242
[TBL] [Abstract][Full Text] [Related]
55. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Jumper JM; Figueroa M;
Ophthalmology; 2009 Mar; 116(3):504-12. PubMed ID: 19167078
[TBL] [Abstract][Full Text] [Related]
56. Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.
Riese J; Loukopoulos V; Meier C; Timmermann M; Gerding H
Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1671-6. PubMed ID: 18709384
[TBL] [Abstract][Full Text] [Related]
57. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.
Rehak J; Rehak M
Curr Eye Res; 2008 Feb; 33(2):111-31. PubMed ID: 18293182
[TBL] [Abstract][Full Text] [Related]
58. Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.
Oh JY; Seo JH; Ahn JK; Heo JW; Chung H
Korean J Ophthalmol; 2007 Mar; 21(1):18-20. PubMed ID: 17460427
[TBL] [Abstract][Full Text] [Related]
59. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections.
Safar A; Dellimore MC
Int Ophthalmol; 2007 Oct; 27(5):307-12. PubMed ID: 17440685
[TBL] [Abstract][Full Text] [Related]
60. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
